SCHEMBL25960041

SCHEMBL25960041

Bc1cc(C=O)cc(O)c1O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ XDH P47989 1/20 0.50
▸ KDM4E B2RXH2 2/20 0.46
▸ PTGS2 P35354 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ ALDH1A1 P00352 3/20 0.38
▸ AOX1 Q06278 1/20 0.38
▸ FNTA P49354 1/20 0.38
▸ FNTB P49356 1/20 0.38
▸ ALDH5A1 P51649 3/20 0.36
▸ ABAT P80404 3/20 0.36
▸ HPGD P15428 2/20 0.34
▸ TDP1 Q9NUW8 2/20 0.34
▸ TRIM24 O15164 1/20 0.34
▸ TRIM33 Q9UPN9 1/20 0.34
▸ ESR1 P03372 1/20 0.34
▸ ESR2 Q92731 1/20 0.34
▸ MEN1 O00255 1/20 0.33
▸ RGS12 O14924 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ EGFR P00533 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL881431 0.88 KDM4E (0.41) XDHKDM4EPTGS2RAB9AALDH1A1
SCHEMBL27935044 0.83 XDH (0.59) XDHKDM4EPTGS2RAB9AALDH1A1
SCHEMBL132439 0.83 XDH (0.59) XDHKDM4EPTGS2RAB9AALDH1A1
SCHEMBL31122716 0.80 XDH (0.57) XDHKDM4EPTGS2RAB9AALDH1A1
Water SCHEMBL36578 0.80 XDH (0.57) XDHKDM4EPTGS2RAB9AALDH1A1
SCHEMBL14154067 0.78 ERN1 (0.44) XDHKDM4EPTGS2RAB9AALDH1A1
SCHEMBL12687888 0.78 SRC (0.47) XDHPTGS2CYP3A4CYP2C9SRC
SCHEMBL1056033 0.74 XDH (0.52) XDHKDM4EPTGS2RAB9AALDH1A1
SCHEMBL1527073 0.74 XDH (0.52) XDHKDM4EPTGS2RAB9AALDH1A1
SCHEMBL30822600 0.74 XDH (0.52) XDHKDM4EPTGS2RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4219504-A1 MACROCYCLIC TLR7 AGONIST, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF Shanghai Visonpharma Co., Ltd. (CN) 2023-08-02 — — EP disclosed
Send feedback